ARISTON GROUP EXERCISES CALL OPTION TO REACH 100% STAKE IN CHROMAGEN AUSTRALIA
27/05/2026
Ariston Group announced that it has exercised the call option to acquire the remaining 49% of Chromagen Australia Pty Ltd (“Chromagen Australia”), already 51% owned and fully consolidated, reaching 100% of the share capital.
The transaction follows the initial acquisition of 51% stake in Chromagen Australia, completed on January 5, 2022. The consideration for the remaining 49% stake amounts to AUD 33.6 million (€20.4 million), as defined in the agreement signed on May 31, 2023 with the minority shareholders. The transaction was settled in cash using Ariston Group’s existing financial resources, not impacting Ariston Group net financial indebtedness according to ESMA guidelines*.
*Refer to Ariston Group 2025 Annual Report, Note 3.13 – Other current liabilities.